All News

FDA Clears Tubeless Automated Insulin-Delivery System for Adults with Type 2 Diabetes
August 27, 2024

The Omnipod 5 is now the first automated insulin delivery system available for both T1D and T2D in the US.

Suicide Rates in US Preteens: Daily Dose
August 27, 2024

Your daily dose of the clinical news you may have missed.

Semaglutide & Suicide: Large Analysis from WHO Data Builds on Previous Research Linking the Two
August 26, 2024

Results of a global analysis of over 30 million cases showed significantly higher odds for suicidal ideation among adults who received semaglutide vs other medications.

US Dementia-Related Mortality Rising with Greatest Impact Among Black Adults, Women, and in Nonurban Areas
August 26, 2024

The increase in the adult population with and at risk for dementia portends future burden among groups and communities with the fewest resources to cope.

Plant-Based Fats Reduce Risk for Overall, CVD Death: Daily Dose
August 26, 2024

Your daily dose of the clinical news you may have missed.

CPAP Therapy May Reduce Hypertensive Disorders of Pregnancy by More than 30%: Meta-Analysis
August 26, 2024

Obstructive sleep apnea during pregnancy increases risk for gestational hypertension and preeclampsia; CPAP therapy may lower risk significantly.

Mpox Outbreak: 5 Things to Know if Patients Ask
August 23, 2024

Now that the WHO has declared a second mpox global emergency, you may want to brush up on knowledge of the disease and the 2024 outbreak.

Tirzepatide Tied to Lower Risk for Death, Adverse CV and Kidney Outcomes vs GLP-1s: Daily Dose
August 23, 2024

Your daily dose of the clinical news you may have missed.

Combination Statin Plus Ezetimibe More Effective than High-Dose Statin to Reduce LDL-C in People with ASCVD
August 23, 2024

In secondary CVD prevention, low/moderate-dose statins plus ezetimibe were superior to high-dose statin for reducing biomarkers, myalgias but did not reduce MACE.

FDA Grants Approval, EUA for Updated mRNA COVID-19 Vaccines
August 22, 2024

The updated COVID-19 vaccines will include a monovalent component corresponding to KP.2, a strain of the Omicron variant of SARS-CoV-2.